Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 302
Filter
1.
Pathologe ; 41(2): 105, 2020 03.
Article in German | MEDLINE | ID: mdl-32124035

Subject(s)
Bone Neoplasms , Humans
2.
HNO ; 65(6): 527-542, 2017 Jun.
Article in German | MEDLINE | ID: mdl-28484788

ABSTRACT

The use of narrow band imaging (NBI) and further technological achievements concerning the resolution and magnification of endoscopic images have revolutionized laryngology in the past 10 years. The diagnosis and therapy of dysplasia and early laryngeal carcinoma have become significantly easier. There are also clear benefits for benign laryngeal lesions. Central to these techniques is the assessment of epithelial, connective tissue and vascular changes caused by diverse diseases.


Subject(s)
Image Enhancement/methods , Laryngeal Diseases/pathology , Laryngeal Mucosa/pathology , Laryngoscopes , Laryngoscopy/instrumentation , Laryngoscopy/methods , Equipment Design , Evidence-Based Medicine , Humans , Laryngeal Diseases/diagnostic imaging , Laryngeal Mucosa/diagnostic imaging , Reproducibility of Results , Sensitivity and Specificity , Technology Assessment, Biomedical
3.
Bone Joint J ; 98-B(8): 1062-8, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27482018

ABSTRACT

AIMS: Tissue responses to debris formed by abrasion of polymethylmethacrylate (PMMA) spacers at two-stage revision arthroplasty for prosthetic joint infection are not well described. We hypothesised that PMMA debris induces immunomodulation in periprosthetic tissues. PATIENTS AND METHODS: Samples of tissue were taken during 35 two-stage revision arthroplasties (nine total hip and 26 total knee arthroplasties) in patients whose mean age was 67 years (44 to 85). Fourier transform infrared microscopy was used to confirm the presence of PMMA particles. Histomorphometry was performed using Sudan Red and Haematoxylin-Eosin staining. CD-68, CD-20, CD-11(c), CD-3 and IL-17 antibodies were used to immunophenotype the inflammatory cells. All slides were scored semi-quantitatively using the modified Willert scoring system. RESULTS: The mean CD-68 scores did not show any significant change during the six weeks between the stages. Perivascular and diffuse scores showed significant difference in CD-3, CD-20, CD-11(c) and IL-17. At the time of re-implantation, a shift in the pattern of the expression of dendritic cells towards a perivascular arrangement and towards the periphery of PMMA particles was observed. Positive microbiological cultures were found at the time of re-implantation in three patients. Five further revisions were required for other reasons. CONCLUSION: Our results represent a biological reaction of the synovial tissues to spacers with a less diffuse expression of dendritic cells and an increased expression of perivascular lymphocytes. The use of spacers in two-stage revision for infection probably induces an immunomodulation of synovial tissues. Cite this article: Bone Joint J 2016;98-B:1062-8.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Arthroplasty, Replacement, Knee/methods , Bone Cements/pharmacology , Polymethyl Methacrylate/pharmacology , Prosthesis-Related Infections/immunology , Adult , Aged , Aged, 80 and over , Analysis of Variance , Antigens, CD/metabolism , Dendritic Cells/immunology , Female , Hip Prosthesis , Humans , Immunomodulation/drug effects , Immunomodulation/immunology , Interleukin-17/metabolism , Knee Prosthesis , Lymphocytes/immunology , Male , Middle Aged , Osteoarthritis, Hip/immunology , Osteoarthritis, Hip/surgery , Osteoarthritis, Knee/immunology , Osteoarthritis, Knee/surgery , Reoperation , Synovial Membrane/immunology
5.
J Cancer Res Clin Oncol ; 140(9): 1457-63, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24825122

ABSTRACT

BACKGROUND: The aim of the current study was to investigate the role of BRCA1 promoter methylation as predictive factor of response to platinum-taxane-based therapy in sporadic ovarian cancer. PATIENTS AND METHODS: BRCA1 promoter methylation was analyzed in 42 sporadic epithelial ovarian cancers. The results were validated in a second cohort of 137 ovarian cancer patients. RESULTS: BRCA1 promoter methylation was observed in 35.7 % of patients in the first group and in 33.6 % in the second group. BRCA1 promoter methylation was associated with significant increase in median progression-free survival (PFS) of ovarian cancer patients receiving adjuvant platinum-taxane-based chemotherapy (P = 0.008). Multivariate analysis revealed that BRCA1 promoter methylation remains a favorable factor in regard to PFS (HR 0.52; 95 % CI 0.32-0.85, P = 0.009) after adjustment for other prognostic factors. Under the patients with recurrent disease, BRCA1 promoter methylation was associated with significant longer median PFS of 18.5 months in comparison with 12.8 months PFS for patients without BRCA1 promoter methylation. CONCLUSIONS: BRCA1 promoter methylation is predictive for better response to platinum-taxane-based therapy in EOC.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , BRCA1 Protein/genetics , Biomarkers, Tumor/genetics , Neoplasms, Glandular and Epithelial/drug therapy , Neoplasms, Glandular and Epithelial/genetics , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/genetics , Promoter Regions, Genetic/genetics , Adult , Aged , Aged, 80 and over , Bridged-Ring Compounds/administration & dosage , Carcinoma, Ovarian Epithelial , Disease-Free Survival , Female , Humans , Methylation/drug effects , Middle Aged , Organoplatinum Compounds/administration & dosage , Prognosis , Taxoids/administration & dosage , Young Adult
8.
Aktuelle Urol ; 44(5): 375-80, 2013 Sep.
Article in German | MEDLINE | ID: mdl-24043537

ABSTRACT

UNLABELLED: ▼HISTORY AND ADMISSION FI NDINGS: A 61-year-old woman presented with a 2-month-history of progressive deterioration, increasing exertional dyspnoea and pain in the right upper abdomen (past medical history: bronchial asthma and hypertension). The physical examination showed mild generalized weakness, tenderness in the right upper abdomen, and ascites. INVESTIGATIONS: Laboratory studies did not reveal any hormonal abnormalities. A CT angiogram revealed a mass of the right adrenal gland with distinct invasion into the inferior vena cava, and tumour thrombosis that extended proximally into the right atrium. Distally, the tumour ended at the caudate lobe of the liver with an extensive peripherally engulfed thrombus from the inferior vena cava down to the common iliac -veins. TREATMENT AND COURSE: An open right adrenalectomy with resection of the periadrenal tissue and exstirpation of the intracaval tumour thrombus (by cavotomy under digital occlusion of the blood flow from the vena cava into the right atrium - cardiac surgeon) was carried out with no significant postoperative complications. Subsequently, the patient underwent adjuvant mitotane therapy for 3 years. So far, no recurrence has occurred during a course of 7 years. CONCLUSION: Tumour induced thrombotic occlusion of the inferior vena cava and other veins is rare, especially with right atrium involvement. In the absence of other effective treatment options, the combination of radical resection and adjuvant mitotane therapy remains the only successful curative treatment for primary invasive pararenal gland carcinoma.


Subject(s)
Adrenal Cortex Neoplasms/pathology , Adrenal Cortex Neoplasms/surgery , Cooperative Behavior , Interdisciplinary Communication , Neoplastic Cells, Circulating/pathology , Vena Cava, Inferior/pathology , Vena Cava, Inferior/surgery , Adrenal Cortex Neoplasms/blood supply , Adrenal Cortex Neoplasms/drug therapy , Adrenalectomy/methods , Angiography , Chemotherapy, Adjuvant , Combined Modality Therapy , Diagnosis, Differential , Embolectomy/methods , Female , Humans , Lymph Node Excision , Middle Aged , Mitotane/adverse effects , Mitotane/therapeutic use , Neoplasm Invasiveness/pathology , Neoplasm Staging , Prognosis , Renal Artery/pathology , Renal Artery/surgery , Tomography, X-Ray Computed
9.
Breast Cancer Res Treat ; 141(2): 205-12, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24026861

ABSTRACT

The aim of the current study was to investigate the role of BRCA1 gene aberrations in sporadic triple-negative breast cancer (TNBC) and its impact on anthracycline-based therapy. BRCA1 promoter methylation was analyzed in 70 TNBC and compared with the clinical and pathologic characteristics. As a control group, we used 70 patients with non-TNBC. BRCA1 promoter methylation was observed in 65.2 % of patients and was similar in both groups. BRCA1 promoter methylation was associated with decreased intensity of BRCA1 protein expression (P = 0.002) and significant increase of median disease-free survival (DFS) of TNBC patients receiving adjuvant anthracycline-based chemotherapy (P = 0.001). Multivariate analysis revealed that BRCA1 promoter methylation remains a favorable factor in regard to DFS (HR 0.224; 95 % CI 0.092-0.546, P = 0.001) in TNBC after adjustment for other prognostic factors. In contrast, in non-TNBC, BRCA1 promoter methylation was not associated with any clinical and pathologic parameters. BRCA1 promoter methylation is a common mechanism of BRCA1 gene aberration in sporadic breast cancer and is predictive for better response to anthracycline-based therapies.


Subject(s)
BRCA1 Protein/genetics , DNA Methylation , Promoter Regions, Genetic , Triple Negative Breast Neoplasms/genetics , Adult , Aged , Aged, 80 and over , Anthracyclines/therapeutic use , Antineoplastic Agents/therapeutic use , BRCA1 Protein/metabolism , Female , Humans , Lymphatic Metastasis , Middle Aged , Mutation , Neoplasm Grading , Prognosis , Treatment Outcome , Triple Negative Breast Neoplasms/drug therapy , Triple Negative Breast Neoplasms/mortality , Triple Negative Breast Neoplasms/pathology , Tumor Burden
10.
Dtsch Med Wochenschr ; 138(6): 260-5, 2013 Feb.
Article in German | MEDLINE | ID: mdl-23361348

ABSTRACT

HISTORY AND ADMISSION FINDINGS: A 61-year-old woman presented with a 2-month-history of progressive deterioration, increasing exertional dyspnoea and pain in the right upper abdomen (past medical history: bronchial asthma and hypertension). The physical examination showed mild generalized weakness, tenderness in the right upper abdomen, and ascites. INVESTIGATIONS: Laboratory studies did not reveal any hormonal abnormalities. A CT angiogram revealed a mass of the right adrenal gland with distinct invasion into the inferior vena cava, and tumour thrombosis that extended proximally into the right atrium. Distally, the tumour ended at the caudate lobe of the liver with an extensive peripherally engulfed thrombus from the inferior vena cava down to the common iliac veins. TREATMENT AND COURSE: An open right adrenalectomy with resection of the periadrenal tissue and extirpation of the intracaval tumour thrombus (by cavotomy under digital occlusion of the blood flow from the vena cava into the right atrium) was carried out with no significant postoperative complications. Subsequently, the patient underwent adjuvant mitotane therapy for three years. So far, no recurrence has occurred during a course of 7 years. CONCLUSION: Tumour induced thrombotic occlusion of the inferior vena cava and other veins is rare, especially with right atrium involvement. In the absence of other effective treatment options, the combination of radical resection and adjuvant mitotane therapy remains the only successful curative treatment for primary invasive adrenal gland carcinoma.


Subject(s)
Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/pathology , Cooperative Behavior , Heart Atria/pathology , Interdisciplinary Communication , Neoplastic Cells, Circulating/pathology , Thrombosis/diagnosis , Thrombosis/pathology , Vena Cava, Inferior/pathology , Adrenal Gland Neoplasms/drug therapy , Adrenal Gland Neoplasms/surgery , Chemotherapy, Adjuvant , Combined Modality Therapy , Female , Follow-Up Studies , Hepatic Veins/pathology , Humans , Iliac Vein/pathology , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Thrombosis/surgery , Tomography, X-Ray Computed , Vena Cava, Inferior/surgery
11.
Cardiovasc Intervent Radiol ; 36(2): 512-20, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22893419

ABSTRACT

PURPOSE: Irreversible electroporation (IRE) is a novel nonthermal tissue ablation technique by high current application leading to apoptosis without affecting extracellular matrix. Previous results of renal IRE shall be supplemented by functional MRI and differentiated histological analysis of renal parenchyma in a chronic treatment setting. METHODS: Three swine were treated with two to three multifocal percutaneous IRE of the right kidney. MRI was performed before, 30 min (immediate-term), 7 days (short-term), and 28 days (mid-term) after IRE. A statistical analysis of the lesion surrounded renal parenchyma intensities was made to analyze functional differences depending on renal part, side and posttreatment time. Histological follow-up of cortex and medulla was performed after 28 days. RESULTS: A total of eight ablations were created. MRI showed no collateral damage of surrounded tissue. The highest visual contrast between lesions and normal parenchyma was obtained by T2-HR-SPIR-TSE-w sequence of DCE-MRI. Ablation zones showed inhomogeneous necroses with small perifocal edema in the short-term and sharp delimitable scars in the mid-term. MRI showed no significant differences between adjoined renal parenchyma around ablations and parenchyma of untreated kidney. Histological analysis demonstrated complete destruction of cortical glomeruli and tubules, while collecting ducts, renal calyxes, and pelvis of medulla were preserved. Adjoined kidney parenchyma around IRE lesions showed no qualitative differences to normal parenchyma of untreated kidney. CONCLUSIONS: This porcine IRE study reveals a multifocal renal ablation, while protecting surrounded renal parenchyma and collecting system over a mid-term period. That offers prevention of renal function ablating centrally located or multifocal renal masses.


Subject(s)
Electroporation/methods , Kidney/pathology , Animals , Apoptosis , Magnetic Resonance Imaging/methods , Male , Models, Animal , Swine
12.
Pathol Res Pract ; 208(5): 269-80, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22541897

ABSTRACT

Barrett's esophagus (BE) is one of the most common premalignant lesions in which normal squamous epithelium of the esophagus is replaced by metaplastic columnar epithelium. Esophageal adenocarcinoma (EA) develops through progression from BE to low- and high-grade dysplasia (LGD/HGD) and to adenocarcinoma. It is widely accepted that inflammation can increase cancer risk, promoting tumor progression. Therefore, inflammation is regarded as the seventh hallmark of cancer. In recent years, the inflammation-cancer connection of Barrett's carcinogenesis has been intensively studied, unraveling genetic abnormalities. Besides genetic alterations, inflammation is also epigenetically linked to loss of protein expression through transcriptional silencing via promoter methylation. Key mediators linking inflammation and Barrett's carcinogenesis include reactive oxygen species (ROS), NFκB, inflammatory cytokines, prostaglandins, and specific microRNAs (miRNAs). Therefore, the decipherment of molecular pathways that contain these and novel inflammatory key mediators is of major importance for diagnosis, therapy, and prognosis. The detailed elucidation of the signaling molecules involved in Barrett's carcinogenesis will be important for the development of pharmaceutical inhibitors. We herein give an overview of the current knowledge of the inflammation-mediated genetic and epigenetic alterations involved in Barrett's carcinogenesis. We highlight the role of oxidative stress and deregulated DNA damage checkpoints besides the NFκB pathway.


Subject(s)
Adenocarcinoma/diagnosis , Barrett Esophagus/diagnosis , Esophageal Neoplasms/diagnosis , Esophagitis, Peptic/pathology , Esophagus/pathology , Gastroesophageal Reflux/diagnosis , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Barrett Esophagus/genetics , Barrett Esophagus/metabolism , DNA Damage , Disease Progression , Epigenesis, Genetic , Esophageal Neoplasms/genetics , Esophageal Neoplasms/metabolism , Esophagitis, Peptic/genetics , Esophagitis, Peptic/metabolism , Esophagus/metabolism , Gastroesophageal Reflux/genetics , Gastroesophageal Reflux/metabolism , Humans , NF-kappa B/metabolism , Oxidative Stress , Reactive Oxygen Species
13.
Clin Exp Metastasis ; 29(8): 889-900, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22552371

ABSTRACT

We investigated the methylation status of mismatch repair gene hMLH1 in 80 primary human endometrial carcinomas (ECs) and in 30 metastatic lesions. It was correlated to the expression of hMLH1 protein, microsatellite instability (MSI) of ECs and to the well-known clinico-pathological variables of cancer. The hMLH1 promoter methylation was detected in 24 out of 64 (37.5 %) primary ECs but only in one out of 18 (5.6 %) metastatic lesions investigated. Promoter hMLH1 hypermethylation was found more often in early stage ECs and was associated with a decrease of hMLH1 protein expression immunohistochemically. An inverse relationship between hMLH1 expression and clinical stage of the disease was found (p = 0.048). Interestingly, there was a significant correlation between MSI and hMLH1 protein expression level (p = 0.042). MSI phenotype was found more often in EC metastases compared to the primary tumors (66.7 % vs 29.3 %; p = 0.039). However, neither hMLH1 promoter hypermethylation nor MSI was independent predictive factors for patient's outcome. Using an in vitro model we showed that hMLH1 methylation is reversible. These data showed that hMLH1 methylation with a consequent protein decrease occurred early during EC tumorigenesis and may cause a MSI phenotype, which occurs relatively late. MSI may be an important mechanism supporting further the tumor progression. These findings may have importance for the specific chemosensitization of the primary tumors/metastases and can improve our understanding of endometrial carcinogenesis in humans.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , DNA Methylation , DNA Repair Enzymes/metabolism , Endometrial Neoplasms/genetics , Endometrial Neoplasms/pathology , Microsatellite Instability , Neoplasm Metastasis/genetics , Nuclear Proteins/metabolism , Adaptor Proteins, Signal Transducing/genetics , Adult , Aged , Aged, 80 and over , Azacitidine/pharmacology , Cell Line, Tumor , DNA Methylation/drug effects , DNA Repair , DNA Repair Enzymes/genetics , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/mortality , Female , Humans , Microsatellite Repeats/genetics , Middle Aged , MutL Protein Homolog 1 , Neoplasm Grading , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Nuclear Proteins/genetics , Phenotype , Prognosis , Promoter Regions, Genetic
14.
Pathologe ; 33(2): 124-8, 2012 Mar.
Article in German | MEDLINE | ID: mdl-22315102

ABSTRACT

The project Pathowiki (www.pathowiki.org) is a free expert database for texts, images, virtual slides and links to all subject areas of pathology in the internet. The aim of this project is to integrate all available information and media, in particular virtual microscopy, to achieve a fast overview of a relevant subject area. Here we present the project's basic functions and applications and evaluate the project with respect to the ongoing digital developments in pathology.


Subject(s)
Databases as Topic/organization & administration , Expert Systems , Internet/organization & administration , Pathology/organization & administration , Computer-Assisted Instruction , Curriculum , Education, Medical, Continuing , Germany , Humans , Pathology/education , User-Computer Interface
15.
J Neurooncol ; 107(3): 503-16, 2012 May.
Article in English | MEDLINE | ID: mdl-22270849

ABSTRACT

Glioblastomas are known to be highly chemoresistant, but HDAC inhibitors (HDACi) have been shown to be of therapeutic relevance for this aggressive tumor type. We treated U87 glioblastoma cells with trichostatin A (TSA) to define potential epigenetic targets for HDACi-mediated antitumor effects. Using a cDNA array analysis covering 96 cell cycle genes, cyclin-dependent kinase inhibitor p21(WAF1) was identified as the major player in TSA-induced cell cycle arrest. TSA slightly inhibited proliferation and viability of U87 cells, cumulating in a G1/S cell cycle arrest. This effect was accompanied by a significant up-regulation of p53 and its transcriptional target p21(WAF1) and by down-regulation of key G1/S regulators, such as cdk4, cdk6, and cyclin D1. Nevertheless, TSA did not induce apoptosis in U87 cells. As expected, TSA promoted the accumulation of total acetylated histones H3 and H4 and a decrease in endogenous HDAC activity. Characterizing the chromatin modulation around the p21(WAF1) promoter after TSA treatment using chromatin immunoprecipitation, we found (1) a release of HDAC1, (2) an increase of acetylated H4 binding, and (3) enhanced recruitment of p53. p53-depleted U87 cells showed an abrogation of the G1/S arrest and re-entered the cell cycle. Immunofluorescence staining revealed that TSA induced the nuclear translocation of p21(WAF1) verifying a cell cycle arrest. On the other hand, a significant portion of p21(WAF1) was present in the cytoplasmic compartment causing apoptosis resistance. Furthermore, TSA-treated p53-mutant cell line U138 failed to show an induction in p21(WAF1), showed a deficient G2/M checkpoint, and underwent mitotic catastrophe. We suggest that HDAC inhibition in combination with other clinically used drugs may be considered an effective strategy to overcome chemoresistance in glioblastoma cells.


Subject(s)
Apoptosis/drug effects , Cell Proliferation/drug effects , Glioblastoma/metabolism , Histone Deacetylase Inhibitors/pharmacology , Hydroxamic Acids/pharmacology , Tumor Suppressor Protein p53/metabolism , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Chromatin Immunoprecipitation , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression Profiling , Glioblastoma/genetics , Humans , Immunoblotting , Oligonucleotide Array Sequence Analysis , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Suppressor Protein p53/genetics
16.
Orthopade ; 41(1): 26-31, 2012 Jan.
Article in German | MEDLINE | ID: mdl-22273704

ABSTRACT

Metallic orthopedic devices are composed of elements known to be skin sensitizers in the general population and metal-on-metal hip prostheses in particular have the theoretical advantage of producing less abrasive wear than metal-on-polyethylene prostheses. However, there is concern about the possibility of hypersensitivity reactions with typical elicitors, such as nickel, chromium or cobalt. These materials are also used for total knee arthroplasty (TKA) and may elicit an immune response the role of which is still unclear in the outcome of arthroplasty. The immune response is dominated by perivascular T and B lymphocyte tissue infiltration around the hip replacement. The infiltrates are mostly surrounded by so-called high endothelial venules. This reaction is associated with periprosthetic osteolysis and aseptic loosening of the prostheses. The differentiation of hypersensitivity and low-grade infection is initially a diagnosis by exclusion using aspiration cultures. The final diagnosis is only resolved by histological investigation of synovial tissue. A close cooperation between orthopedic surgeons, pathologists and microbiologists is necessary to diagnose specific cellular differences in hypersensitivity and infection in tissue investigations.


Subject(s)
Bacterial Infections/diagnosis , Hypersensitivity/diagnosis , Hypersensitivity/etiology , Metals/adverse effects , Prosthesis-Related Infections/diagnosis , Diagnosis, Differential , Humans , Hypersensitivity/prevention & control
17.
Pathologe ; 32(4): 303-13, 2011 Jul.
Article in German | MEDLINE | ID: mdl-21688020

ABSTRACT

Biopsies and resection specimens of the gastrointestinal tract are a major part of the routine workload in many histopathology departments, whereby polypoid lesions are generally the main focus. In addition to distinguishing non-neoplastic from neoplastic polyps and evaluating the grade of dysplasia of the latter, the pathologist should always consider the possibility of an underlying polyposis syndrome. Not only have additional hereditary polyposis syndromes been identified in recent years due to a better understanding of their genetic and epigenetic alterations but also knowledge on well known polyposes has improved, leading to subtyping of various forms according to their different genotype. It is essential for the histopathologist to understand that the conventional histomorphology of individual polyps combined with information on the number and distribution of these lesions and clinical data can provide clues regarding a possible hereditary background. Therefore, the correct histological assessment of polyps is not just about getting the diagnosis right, it might also lead to genetic screening of family members and spouses.


Subject(s)
Adenomatous Polyposis Coli/pathology , Adenomatous Polyposis Coli/classification , Adenomatous Polyposis Coli/genetics , Adenomatous Polyposis Coli Protein/genetics , Adolescent , Adult , Child , Child, Preschool , Chromosomes, Human, Pair 5/genetics , Colonoscopy , Cooperative Behavior , DNA Glycosylases/genetics , DNA Mutational Analysis , Diagnosis, Differential , Genetic Testing , Humans , Infant , Interdisciplinary Communication , Intestinal Mucosa/pathology , Intestinal Polyposis/congenital , Intestinal Polyposis/genetics , Intestinal Polyposis/pathology , Neoplastic Syndromes, Hereditary , Patient Care Team , Peutz-Jeghers Syndrome/genetics , Peutz-Jeghers Syndrome/pathology , Young Adult
18.
Pathologe ; 31 Suppl 2: 177-82, 2010 Oct.
Article in German | MEDLINE | ID: mdl-20661574

ABSTRACT

In contrast to normal cartilage, which is avascular, angiogenesis is characteristic of cartilage tumors. In this review, we outline the basic principles of angiogenesis with regard to recent findings on differential morphological and molecular aspects of angiogenesis in cartilage tumors, including enchondromas, conventional chondrosarcomas and dedifferentiated chondrosarcomas. Furthermore, we describe the effects of hypoxia and interleukin-1ß on angiogenic signaling in chondrosarcoma cells.


Subject(s)
Bone Neoplasms/blood supply , Bone Neoplasms/pathology , Cartilage Diseases/pathology , Cartilage/blood supply , Chondroma/blood supply , Chondroma/pathology , Chondrosarcoma/blood supply , Chondrosarcoma/pathology , Neovascularization, Pathologic/pathology , Cell Hypoxia/physiology , Humans , Interleukin-1beta/physiology , Signal Transduction , Vascular Endothelial Growth Factor A/physiology
19.
Laryngorhinootologie ; 89(5): 266-9, 2010 May.
Article in German | MEDLINE | ID: mdl-20458657

ABSTRACT

BACKGROUND: The best known clinical picture of a one-sided necrotisising, infectious tonsillitis is the by Plaut and Vincent (1894) described angina Plaut-Vincent. In addition to this fusospirochetosis it is in case of necrotisising inflammations in the oropharynx differential-diagnostically important to consider also the anaerobic type Prevotella, especially Prevotella disiens as a potential trigger . MATERIAL AND METHODS: Because the clinical course forms of a necrotisising oropharyngeal inflammations can be very different and complicate so a suitable diagnosis, it is very important to get a complete and perfect cause proof. For getting this proof a correct test production, transport and cultivation are of extreme importance . RESULTS: The type Prevotella consists of different species gram-negative, obligate anaerobic strains. They are regarded as a cause of suppurating inflammations and abscesses of the genital tract and are components of the aerobic anaerobic mixed flora in case of gingival infections. The sole proof in the microbiological culture as a smear test result of a one-sided necrotisising tonsillitis has to be seen as a first description by reason of missing literature . IMPLICATION: As triggers for one-sided necrotisising tonsillitis are considered different causes. Next a carcinoma of the tonsil, Lues, Angina Plaut-Vincent have to be excluded. An infection with Prevotella disiens is an extremely rare variation in contrast. However, the transmission is possible by insufficient hygiene, lack phenomena and sexual intercourse and to consider therefore as an exclusion diagnosis.


Subject(s)
Bacterial Infections/diagnosis , Palatine Tonsil/pathology , Tonsillitis/diagnosis , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/pathology , Bacterial Infections/therapy , Bacteriological Techniques , Bacteroidaceae Infections/diagnosis , Bacteroidaceae Infections/pathology , Bacteroidaceae Infections/therapy , Diagnosis, Differential , Fusobacterium Infections/diagnosis , Fusobacterium Infections/pathology , Fusobacterium Infections/therapy , Gingivitis, Necrotizing Ulcerative/diagnosis , Gingivitis, Necrotizing Ulcerative/pathology , Gingivitis, Necrotizing Ulcerative/therapy , Humans , Necrosis , Oral Ulcer/diagnosis , Prevotella , Syphilis/diagnosis , Syphilis/drug therapy , Syphilis/pathology , Tonsillectomy , Tonsillitis/pathology , Tonsillitis/therapy
20.
Z Gastroenterol ; 48(5): 555-9, 2010 May.
Article in German | MEDLINE | ID: mdl-20140844

ABSTRACT

BACKGROUND: Despite its rare occurrence, inflammatory myofibroblastic pseudotumour (IMT) is relevant in the differential diagnosis of intestinal lesions. By the mean of an extraordinary case report, tumour site and specific characteristics, finding of the correct diagnosis, therapeutic management, and outcome of extrapulmonary IMT is decribed based also on relevant references from the literature. CASE REPORT: A 39-year old man experienced a multifocal thoracic recurrence and abdominal metastasis of IMT 12 years after successful primary resection of pulmonary IMT. The intra-abdominal lesion localised in the jejunal mesenteric tissue was removed surgically (resection status, R 0) by segmental resection of the mid-jejunum (length: 80 cm) followed by jejunojejunostomy. Histology evaluation confirmed IMT. Thoracic surgeons advised against a surgical approach to the pulmonary and thoracic lesions because of their number and proximity to the superior vena cava as well as mediastinal infiltration. Despite receiving repeated advice from his physicians, the patient has not agreed to combined immunosuppressive treatment with cyclophosphamide and steroids, because of his desire for children. He underwent 5 months of systemic steroid treatment, starting in the third postoperative month, which he then chose to stop because of Cushing symptomatology. He agreed to a computed tomography (CT) scan follow-up 12 months after surgery, which revealed slight local progression of the remaining pulmonary lesion. Administration of a second steroid medication was initiated at a lower dose. No further CT scans were obtained. At present, he is consulting with an alternative medicine practitioner. CONCLUSION: This report documents a rarely described case of IMT at a jejunal mesenteric tumour site, interpreted as an uncommon late and extraordinary, metastatic, multifocal recurrence found 12 years (!) after surgical resection of the primary pulmonary tumour.


Subject(s)
Granuloma, Plasma Cell/surgery , Jejunal Neoplasms/secondary , Jejunal Neoplasms/surgery , Lung Neoplasms/surgery , Mesentery , Neoplasm Recurrence, Local/surgery , Neoplasms, Muscle Tissue/secondary , Neoplasms, Muscle Tissue/surgery , Peritoneal Neoplasms/secondary , Peritoneal Neoplasms/surgery , Adrenal Cortex Hormones/administration & dosage , Adult , Disease Progression , Follow-Up Studies , Granuloma, Plasma Cell/pathology , Humans , Jejunal Neoplasms/pathology , Jejunum/surgery , Lung Neoplasms/pathology , Male , Neoplasm Recurrence, Local/pathology , Neoplasms, Muscle Tissue/pathology , Peritoneal Neoplasms/pathology , Reoperation , Tomography, X-Ray Computed , Treatment Refusal
SELECTION OF CITATIONS
SEARCH DETAIL
...